of different buffers and buffer concentrations to optimize the rate of chemical activation of perhydrolysis by different buff› ers to identify the preferred mode of the invention. In the present invention, the reference standards were established for the purpose of creating formulations with optimum: (i) rates of perhydrolysis of the percarboxylic acid sources; (ii) stocihiometries of activator and reactive species for maxi› mum activated life (pot life); and (iii) optimum efficacy against known threat loads oftoxants. Establishing such ref› erence standards against which the efficacy of other formu› lations could be compared was an important invention. 

[0270] In the preferred embodiments of the present inven› tion, the method of chemical activation is not a simple pH adjustment with a base, but instead is an activation by a buffering system in which the buffering capacity is used to establish the quasi-steady state equilibrium of reactive spe› cies production as described above. A second aspect of the preferred embodiment of the invention is that the stoichiom› etry of the activator and reactive oxygen species is optimized to provide the greatest rate and efficacy in reducing threat loads of chemical or biological toxants. In yet a third aspect of the preferred embodiment of the invention, the kit configura› tion is binary. It is yet a fourth aspect of the preferred embodi› ment of the invention that such a kit would have a small logistical footprint. A fifth aspect of the preferred embodi› ment of the invention is that it can be readily aerosolized as a spray. A sixth aspect of the preferred embodiment of the invention is a formulation that is easy and safe to ship, store, use, and cleanup. Finally, a preferred embodiment of the invention is that the formulation is environmentally safe to use and has excellent materials compatibility. 

[0271] The invention also relates to a quaternary kit 1300 comprising a kit container 1310 for the components to pre› pare a chemical or biological decontaminant solution. The kit container 1310 can be, but is not limited to, a suitcase, a box, or a bucket-type kit container. The kit container 1310 can be opaque or transparent. If transparent, an end user is able to determine if the kit 1300 contains the exact components desired. The kit can comprise at least at least one polar organic amphipathic solvent Base Mix 1320, at least one dry or liquid activators or sources thereof, 1330 and 1340, and at least one liquid or dry reactive oxygen species, 1350. The solvent can be a polar aprotic solvent, a polar-protic solvent, or combinations thereof. Further, the solvent can be a nitrile, a ketone, an aldehyde, a carboxylic acid, an amide, a furan, an alkanol or a polyol. The volume fraction of water in decon› taminant solution can range from about 25% to about 80% or from about 25% to about 75%, and the pH of the solution can be less than or equal to about 8.5. More specifically, the polar amphipathic solvents can be butanediol, an isomer ofbutane› diol, 1-hexanol, a linear or branched-chain alcohol with 1 to 15 carbons, an n-alcohol, a butoxy-alcohol, or a combination thereof. The active oxygen species can be tetraacetylethyl› enediamine (TAED) or tetraacetylmethylenediamine (TAMD). Alternatively, the pH can be maintained at less than or equal to about 8.0. The invention is active against all agents as pH values between about 7.0 to about 10.5; the buffer capacity is more effective at pH values between about 8.0 to about 9.0. However, for maximum active life, the preferred embodiment is maintained a pH values from about 8.0 to about 8.5. The pH can further be maintained at a pH of about 8.5. 

## Example 10 

[0272] The at least one liquid or dry activator 1330, 1340 of the quaternary kit can comprise any peroxide or persulfate which is the source in the decontaminant solution of hydroxyl radicals, hydroxyl ions, super oxides, or other oxidizers, which perhydrolyze the reactive oxygen species source. In addition, the at least one reactive oxygen species 1350 can comprise peroxyacetic acid or its source, a first activator 1330 that is a hydrogen peroxide activator and a second activator 1340 that comprises a buffer system, which includes, but is not limited to, carbonate or sodium hydroxide based buffer systems. The kit of the invention can further comprise a block co-polymer, which would be pre-mixed with the base mix solvent 1320, wherein the block co-polymer can be ethylene oxide and propylene oxide co-polymer that terminates in primary hydroxyl groups. 

[0273] The quaternary kit can also comprise a container 1360 for mixing the solution, the at least one solvent 1320, at least one dry or liquid activator or source thereof 1330, 1340, and at least one reactive oxygen species 1350, which can be combined together into a decontamination mixture, along with means for physically associating the decontamination mixture with the toxant. The quarternary kit 1310 can use a wide variety of materials to store the components of the system, such as vessels made ofbut not limited to, metal, clear glass, colored glass or plastic. 

[0274] The means for physically associating the decon› tamination mixture with the toxant can comprise an applica› tor 1380 including, but not limited to, an aerosolization nozzle. The kit container 1310 can comprise a handle 1370 for carrying the kit container with components. The kit container 1310 can also comprise wheels for ease of transport (not shown). Further, the kit can comprise instructions for use 1390. 

[0275] The invention also relates to a binary kit 1400 com› prising a kit container 1410 for the components to prepare a chemical or biological decontaminant solution. The kit con› tainer 1410 can be, but is not limited to, a suitcase, a box, or a bucket-type kit container. The kit container 1410 can be, but is not limited to, a suitcase, a box, or a bucket-type kit con› tainer. The kit container 1410 can be opaque or transparent. If transparent, an end user is able to determine if the kit 1400 contains the exact components desired. The kit, or system, 1400 can comprise: (i) a liquid Base Mix 1420, comprising at least at least one polar organic amphipathic solvent and a reactive oxygen species or its source, and (ii) at least one dry or liquid activator or source thereof 1430. The solvent(s) can be a polar aprotic solvent, a polar-protic solvent, or combi› nations thereof. Further, the solvent(s) can be a nitrile, a ketone, an aldehyde, a carboxylic acid, an amide, a furans, an alkanol, or a polyol. The volume fraction of water in decon› taminant solution can range from about 25% to about 75%, and the pH of the solution can less than or equal to about 8.5. More specifically, the polar amphipathic solvents can be butanediol, an isomer of butanediol, a linear or branched› chain alcohol with 1 to 15 carbons, an n-alcohol, a butoxy› alcohol, other polyols, or a combination thereof. The active oxygen species can betetraacetylethylenediamine (TAED) or tetraacetylmethylenediamine (TAMD). Alternatively, the at least one reactive oxygen species can comprise peroxyacetic acid or its source. Alternatively, the pH can be maintained at less than or equal to about 8.0. The invention is active against all agents as pH values between about 7.0 to about 10.5; the 

## Example 11 

